SUPN icon

Supernus Pharmaceuticals
SUPN

Upgrade to unlock
Buy
Hold
Sell

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$60
16% upside
High target

3 analyst ratings

positive
1  neutral
33%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Stifel
Stifel
Annabel Samimy
19 Dec ‘25 27 days ago
BofA Securities
BofA Securities
Pavan Patel
0% 1-yr SUPN win rate
29 Oct ‘25 2 months ago
TD Cowen
TD Cowen
Stacy Ku
100% 1-yr SUPN win rate
23 Oct ‘25 2 months ago